Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Area of interest

Area of interest

Type (1 selected)

Type

Guidance programme

Showing 1401 to 1425 of 2003

Published guidance, NICE advice and quality standards
TitleReference numberPublishedLast updated
Aflibercept for treating diabetic macular oedemaTA346
Nintedanib for previously treated locally advanced, metastatic, or locally recurrent non‑small‑cell lung cancerTA347
Everolimus for preventing organ rejection in liver transplantationTA348
Secukinumab for treating moderate to severe plaque psoriasisTA350
Cangrelor for reducing atherothrombotic events in people undergoing percutaneous coronary intervention or awaiting surgery requiring interruption of anti‑platelet therapy (terminated appraisal)TA351
Insertion of an epiretinal prosthesis for retinitis pigmentosaIPG519
Radiofrequency ablation for gastric antral vascular ectasiaIPG520
Suture fixation of acute disruption of the distal tibiofibular syndesmosisIPG521
Ultrasound‑enhanced, catheter‑directed thrombolysis for deep vein thrombosisIPG523
Ultrasound‑enhanced, catheter‑directed thrombolysis for pulmonary embolismIPG524
Electrotherapy for the treatment of haemorrhoidsIPG525
Implantation of a sphenopalatine ganglion stimulation device for chronic cluster headacheIPG527
Omalizumab for previously treated chronic spontaneous urticariaTA339
Vedolizumab for treating moderately to severely active ulcerative colitisTA342
Apixaban for the treatment and secondary prevention of deep vein thrombosis and/or pulmonary embolismTA341
Lower urinary tract symptoms in men: managementCG97
Obinutuzumab in combination with chlorambucil for untreated chronic lymphocytic leukaemiaTA343
Challenging behaviour and learning disabilities: prevention and interventions for people with learning disabilities whose behaviour challengesNG11
Violence and aggression: short-term management in mental health, health and community settingsNG10
Implantation of a left ventricular assist device for destination therapy in people ineligible for heart transplantationIPG516
Insertion of endobronchial nitinol coils to improve lung function in emphysemaIPG517
Implantation of a duodenal–jejunal bypass liner for managing type 2 diabetesIPG518
Rivaroxaban for preventing adverse outcomes after acute management of acute coronary syndromeTA335
Empagliflozin in combination therapy for treating type 2 diabetesTA336
Rifaximin for preventing episodes of overt hepatic encephalopathyTA337

Results per page

  1. 10
  2. 25
  3. 50
  4. All